Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 433

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study

Open access
Li, Xiangchun, Zhang, Sheng, Zhang, Qiang, Wei, Xi, Pan, Yi, Zhao, Jing, Xin, Xiaojie, Qin, Chunxin, Wang, Xiaoqing, Li, Jianxin, Yang, Fan, Zhao, Yanhui, Yang, Meng, Wang, Qinghua, Zheng, Zhiming, Zheng, Xiangqian, Yang, Xiangming, Whitlow, Christopher T, Gurcan, Metin Nafi, Zhang, Lun, Wang, Xudong, Pasche, Boris C, Gao, Ming, Zhang, Wei, Chen, Kexin·2019·The Lancet Oncology

Abstract

Summary Background The incidence of thyroid cancer is rising steadily because of overdiagnosis and overtreatment conferred by widespread use of sensitive imaging techniques for screening. This overall incidence growth is especially driven by increased diagnosis of indolent and well-differentiated papillary subtype and early-stage thyroid cancer, whereas the incidence of advanced-stage thyroid cancer has increased marginally. Thyroid ultrasound is frequently used to diagnose thyroid cancer. The aim of this study was to use deep convolutional neural network (DCNN) models to improve the diagnostic accuracy of thyroid cancer by analysing sonographic imaging data from clinical ultrasounds. Methods We did a retrospective, multicohort, diagnostic study using ultrasound images sets from three hospitals in China. We developed and trained the DCNN model on the training set, 131 731 ultrasound images from 17 627 patients with thyroid cancer and 180 668 images from 25 325 controls from the thyroid imaging database at Tianjin Cancer Hospital. Clinical diagnosis of the training set was made by 16 radiologists from Tianjin Cancer Hospital. Images from anatomical sites that were judged as not having cancer were excluded from the training set and only individuals with suspected thyroid cancer underwent pathological examination to confirm diagnosis. The model’s diagnostic performance was validated in an internal validation set from Tianjin Cancer Hospital (8606 images from 1118 patients) and two external datasets in China (the Integrated Traditional Chinese and Western Medicine Hospital, Jilin, 741 images from 154 patients; and the Weihai Municipal Hospital, Shandong, 11 039 images from 1420 patients). All individuals with suspected thyroid cancer after clinical examination in the validation sets had pathological examination. We also compared the specificity and sensitivity of the DCNN model with the performance of six skilled thyroid ultrasound radiologists on the three validation sets. Findings Between Jan 1, 2012, and March 28, 2018, ultrasound images for the four study cohorts were obtained. The model achieved high performance in identifying thyroid cancer patients in the validation sets tested, with area under the curve values of 0·947 (95% CI 0·935–0·959) for the Tianjin internal validation set, 0·912 (95% CI 0·865–0·958) for the Jilin external validation set, and 0·908 (95% CI 0·891–0·925) for the Weihai external validation set. The DCNN model also showed improved performance in identifying thyroid cancer patients versus skilled radiologists. For the Tianjin internal validation set, sensitivity was 93·4% (95% CI 89·6–96·1) versus 96·9% (93·9–98·6; p=0·003) and specificity was 86·1% (81·1–90·2) versus 59·4% (53·0–65·6; p<0·0001). For the Jilin external validation set, sensitivity was 84·3% (95% CI 73·6–91·9) versus 92·9% (84·1–97·6; p=0·048) and specificity was 86·9% (95% CI 77·8–93·3) versus 57·1% (45·9–67·9; p<0·0001). For the Weihai external validation set, sensitivity was 84·7% (95% CI 77·0–90·7) versus 89·0% (81·9–94·0; p=0·25) and specificity was 87·8% (95% CI 81·6–92·5) versus 68·6% (60·7–75·8; p<0·0001). Interpretation The DCNN model showed similar sensitivity and improved specificity in identifying patients with thyroid cancer compared with a group of skilled radiologists. The improved technical performance of the DCNN model warrants further investigation as part of randomised clinical trials. Funding The Program for Changjiang Scholars and Innovative Research Team in University in China, and National Natural Science Foundation of China.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(18)30762-9

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 433

Metadata

Authors
Li, X., Zhang, S., Zhang, Q., Wei, X., Pan, Y., Zhao, J., Xin, X., Qin, C., Wang, X., Li, J., Yang, F., Zhao, Y., Yang, M., Wang, Q., Zheng, Z., Zheng, X., Yang, X., Whitlow, C. T., Gurcan, M. N., Zhang, L., Wang, X., Pasche, B. C., Gao, M., Zhang, W., & Chen, K.
Venue
The Lancet Oncology
Publisher
Elsevier BV
Published
2019-02
Volume
20
Issue
2
Pages
193-201
ISSN
1470-2045 (ISSN-L)
OpenAlex
W2905949064
Cited by
433
References
26
FWCI
20.23
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study. https://app.cochat.ai/papers/10.1016/s1470-2045(18)30762-9
The paper
Li, X., Zhang, S., Zhang, Q., Wei, X., Pan, Y., Zhao, J., Xin, X., Qin, C., Wang, X., Li, J., Yang, F., Zhao, Y., Yang, M., Wang, Q., Zheng, Z., Zheng, X., Yang, X., Whitlow, C. T., Gurcan, M. N., . . . Chen, K. (2019). Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(18)30762-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.